We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $2.66B
1-Year Est. Return 22.31%
This Fund
S&P 500
This Quarter Est. Return
-2.18%
1 Year Est. Return
+22.31%
3 Year Est. Return
+37.18%
5 Year Est. Return
+53.37%
10 Year Est. Return
AUM
$2.66B
AUM Growth
-$371M
Cap. Flow
-$244M
Cap. Flow %
-9.17%
Top 10 Hldgs %
30.22%
Holding
991
New
109
Increased
209
Reduced
514
Closed
129

Sector Composition

Rank Sector Weight
1 Healthcare 18.19%
2 Technology 12.3%
3 Financials 6.8%
4 Industrials 6.61%
5 Consumer Discretionary 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
651
Relay Therapeutics
RLAY
$4.25B
$284K 0.01%
28,573
+3,453
+14% +$30.9K
LITE icon
652
Lumentum
LITE
$67.2B
$283K 0.01%
+403
New +$221K
IRWD icon
653
Ironwood Pharmaceuticals
IRWD
$729M
$283K 0.01%
80,567
-7,408
-8% -$30.4K
COLM icon
654
Columbia Sportswear
COLM
$2.98B
$283K 0.01%
5,159
+734
+17% +$42.2K
SDRL icon
655
Seadrill
SDRL
$2.61B
$282K 0.01%
6,204
-311
-5% -$12.7K
SHW icon
656
Sherwin-Williams
SHW
$87.4B
$282K 0.01%
880
-6
-0.7% -$2.06K
BULL
657
Webull Corp
BULL
$4.01B
$282K 0.01%
+58,741
New +$381K
DV icon
658
DoubleVerify
DV
$1.82B
$282K 0.01%
29,636
+12,631
+74% +$129K
LNC icon
659
Lincoln National
LNC
$8.96B
$281K 0.01%
7,922
+74
+0.9% +$2.84K
GPN icon
660
Global Payments
GPN
$23.8B
$281K 0.01%
+4,175
New +$308K
BXSL icon
661
Blackstone Secured Lending
BXSL
$5.52B
$279K 0.01%
11,784
-11,737
-50% -$292K
WRBY icon
662
Warby Parker
WRBY
$3.63B
$275K 0.01%
13,059
+2,570
+25% +$63.7K
ACAD icon
663
Acadia Pharmaceuticals
ACAD
$4.45B
$274K 0.01%
12,291
-901
-7% -$21.5K
NOBL icon
664
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$272K 0.01%
5,134
CHTR icon
665
Charter Communications
CHTR
$17.6B
$271K 0.01%
1,256
-746
-37% -$162K
FRSH icon
666
Freshworks
FRSH
$3.3B
$271K 0.01%
33,751
+7,792
+30% +$71.9K
QAI icon
667
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
$271K 0.01%
7,935
DRS icon
668
Leonardo DRS
DRS
$12.1B
$270K 0.01%
6,075
+201
+3% +$8.47K
DOCS icon
669
Doximity
DOCS
$3.96B
$270K 0.01%
+11,603
New +$362K
BR icon
670
Broadridge
BR
$19.7B
$269K 0.01%
+1,656
New +$315K
PGR icon
671
Progressive
PGR
$122B
$268K 0.01%
1,350
-2,092
-61% -$432K
EPAM icon
672
EPAM Systems
EPAM
$5.61B
$268K 0.01%
+1,976
New +$338K
ZTS icon
673
Zoetis
ZTS
$31.5B
$267K 0.01%
2,256
-129
-5% -$16K
KEY icon
674
KeyCorp
KEY
$24.8B
$266K 0.01%
13,289
-7,061
-35% -$148K
SH icon
675
ProShares Short S&P500
SH
$902M
$266K 0.01%
+7,000
New +$255K

Similar funds

Pallas Capital Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Pallas Capital Advisors held 991 positions worth $2.66B, down 12% from $3.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pallas Capital Advisors withdrew a net $244M in Q1 2026, closing 129 positions and reducing 514 holdings. Its most notable exit was Janus Henderson B-BBB CLO ETF, an estimated $23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Pallas Capital Advisors opened a new position in iShares 1-3 Year Treasury Bond ETF worth $14.2M.

  • Pallas Capital Advisors's largest Q1 2026 buy was iShares 1-3 Year Treasury Bond ETF: 171,450 shares worth $14.2M.
  • Pallas Capital Advisors added most to Janus Henderson AAA CLO ETF in Q1 2026, an estimated $20.9M increase.
  • Pallas Capital Advisors's biggest Q1 2026 reduction was JPMorgan BetaBuilders International Equity ETF, cutting an estimated $17.3M.
  • Pallas Capital Advisors fully exited Janus Henderson B-BBB CLO ETF in Q1 2026, selling an estimated $23M.
  • Pallas Capital Advisors's ten largest holdings make up 30% of its $2.66B portfolio in Q1 2026.
  • Pallas Capital Advisors opened 109 new positions and closed 129 in Q1 2026.
  • Pallas Capital Advisors's portfolio value fell 12% quarter-over-quarter to $2.66B.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.